News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Topaz Pharmaceuticals Receives $20 million Series A Financing


12/3/2007 12:37:51 PM

PHILADELPHIA--(BUSINESS WIRE)--Topaz Pharmaceuticals Inc., a pharmaceutical company dedicated to the health and well being of children, today announced that it has secured $20 million in Series A financing from Aisling Capital (New York) and Fidelity Biosciences (Boston). The funds will be used to help Topaz complete clinical trials of the company’s new prescription medicine to fight head lice, and prepare the product for market.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES